sales
Eli Lilly predicts revenue growth in 2016
January 5, 2016Research and Development, Sales and Marketing Eli Lilly, financial reports, marketing, sales
Eli Lilly has set out its financial guidance for 2016, predicting an increase in sales to between $20.2 and $20.7 …
Experts predict pharma sector to remain strong in 2016
December 21, 2015Sales and Marketing marketing, pharma, profits, sales
The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …
Merck on the march in Africa
December 21, 2015Sales and Marketing Africa, Merck, marketing, sales, strategy
When Merck unveiled its Africa 2020 strategy in November, there was no shortage of ambition.The company announced plans to expand …
Analysts say pharma R&D returns challenged by drag of high costs
December 16, 2015Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts
The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …
Pharma company vows to plough profits back into R&D
November 30, 2015Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise
An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …
Top 5 pharma companies’ Q3 results
November 6, 2015Medical Communications, Sales and Marketing financial results, revenue, sales
The leading pharma players have been able to report largely positive financial results to their shareholders in the third quarter …
ANALYSIS: The challenges of forecasting biosimilar sales across Europe
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts
The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …
Brandicourt set to continue Sanofi restructure
September 28, 2015Sales and Marketing Merial, Sanofi, olivier brandicourt, restructuring, sales, spin-off
Sanofi chief executive Olivier Brandicourt is considering sales or spin-offs of a number of the company’s divisions, as part of …
Sandoz and pharma division boost Novartis sales
July 21, 2015Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales
Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …
GSK blames respiratory woes as sales drop
February 5, 2015Sales and Marketing Advair, GSK, GlaxoSmithKline, HIV, ViiV, Witty, anoro ellipta, breo, lovaza, q4, sales
GlaxoSmithKline’s respiratory business has been flagged as the key factor in the firm’s fourth quarter financial misfortunes, as its total …
Lacklustre sales hit Lilly again
October 24, 2014Sales and Marketing Q3, cymbalta, humilin, lilly, sales, zyprexa
Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …
The end of salesmanship?
August 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Rose, a bpi, all trials, evidence, gold acre, sales, salesmanship
Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …
Another major drop in sales for GSK
July 23, 2014Sales and Marketing China, GSK, Q2, Witty, bribery, sales, scandal, sex
GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …
Merck’s Q1 sales drop
April 30, 2014Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales
Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …
GSK China rep speaks out over ‘bribery culture’
April 2, 2014Medical Communications, Sales and Marketing China, GSK, Shanghai, Witty, bribery, sales
A former sales representative for GlaxoSmithKline has spoken of the firm’s alleged tactics in bribing poorly paid doctors in China …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
